Rapt Therapeutics, Inc. (RAPT)

35.10 +2.91 (+9.04%) USD  |  NASDAQ  |  Jan 16, 16:00
34.98 -0.12 (-0.33%) After-Hours: 20:00
More

Rapt Therapeutics EBITDA (TTM)

EBITDA (TTM) Chart

View EBITDA (TTM) for RAPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (TTM) Range, Past 5 Years

View EBITDA (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (TTM) Benchmarks

View EBITDA (TTM) Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade